*GVBP +30% – Receives BUY ALERT with $1.12 Price Target From Research Firm! *
Sep 15th, 2009 by beststockreport
Hi All,
I mentioned that GVBP would be my BIGGEST PICK EVER.
GVBP is now up over 100% since my initial Alert!
Congrats to all who were able to profit from our Alert!
GVBP is far from being over. In fact, GVBP was just covered by a Research Firm!
GVBP received a BUY ALERT with a $1.12 Price target!
Link to the Research Report: http://www.grassrootsrd.com/gvbp-report.pdf
GVBP closed at 29 cents with over 70 million shares in volume!
GVBP traded over 21 million dollar in volume! There is obviously something up with GVBP!
I mentioned that GVBP could spark the interest of Venture Capital, Hedge Funds, and big Institutions. With the volume we saw on Friday, this could be the start of something HUGE!
GVBP closed at 29 cents and with a PRICE TARGET of $1.12 from the Research Report, there could be MUCH more upside for the Stock!
VNDA, CTIC and HGSI all soared over 1000% in the past few months!
GVBP could be the next bio stock to go INSANE!
Make sure you WATCH GVBP tomorrow for more ACTION!
If you missed our initial profile on GVBP see below:
http://genovabio.com
About GVBP
GENova (OTCBB: GVBP) is a biotechnology drug development company focused on the development and commercial licensure of new drug targets for treatment and prevention of cancers and other infectious diseases. The Company, through its extensive global network and expertise in evaluating projects/IP, identifies and validates promising early-stage, or already patented discovery projects. These drugs target disease indications with significant unmet needs, and have substantial market potential.
**GVBP to potentially reach 1 billion dollar in royalty fees!**
I mentioned in my initial report that GVBP was a RARE opportunity in the market.
I mentioned that GVBP was up to something big!
And with the PR released on Thursday it confirms my assessment of the Company!
This is the type of announcement that could bring huge interest from the Street!
If you miss the PR announced today click the link below:
http://www.reuters.com/article/pressRelease/idUS198952+10-Sep-2009+PRN20090910
Basically, GVBP announced that they are in the process of acquiring 3 new drugs that could yield 1 billion dollar in royalty fees!
If GVBP is able to reach 1 billion dollar in royalty fee the stock could be valued at a MUCH higher price level!
I wouldn’t be surprise to see GVBP move higher tomorrow!
GVBP will attract a lot of interest with such a powerful Press Release!
Venture Capital, Hedge Fund, and various financial institutions could take a serious position in GVBP!
These potential big buyers could drive the stock even higher!
**The Stars are Lining up for GVBP!**
GVBP announced Wednesday that their drugs could yield up to 400 million dollar in revenue!
Today GVBP announced that 3 pending drug acquisitions could yield up to 1 billion in royalty fee!
If both statements become true, GVBP could have close to 1.4 billion dollar in revenue stream!
Yesterday’s PR also stated the following:
Big Pharma presently has $215 Billion to spend on licensing of new drugs, and is eager to feed the pipeline for new anti-cancer drugs, as cancer represents the largest disease market, and has an explosive growth rate of 20% per annum. Of the types of cancer, prostate cancer represents the largest market and breast cancer the second.
This is a PERFECT opportunity for GVBP since their products focus on Prostate and Breast Cancer!
If GVBP develop efficient products and acquire their 3 new drugs they could become a perfect take over candidate for big pharmaceutical companies like Pfizer, Amgen or Glaxo Smith Kline!
The Stars are clearly lining up for GVBP!
Make sure you Watch GVBP tomorrow for another Active Day!
MonsterStox.com Team
**********************
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. We might buy or sell this security without notice. Always do your own due diligence before investing in any stock mentioned in this newsletter. The disclaimer is to be read and fully understood before using our site, or joining our email list.
PLEASE NOTE WELL: The MonsterStox.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at:
http://www.MonsterStox.com/Disclaimer.html
Release of Liability: MonsterStox.com is wholly owned and operated by Golden Dragon Media Inc. Through use of this website viewing or using you agree to hold MonsterStox,.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not puport to be a complete statement or summary of the available data. The third party may have shares and may liquidate it, which may negatively affect the stock price. Monsterstox.com received ten thousand dollar for a one month profile of GVBP from a Third Party. We are currently negotiating for more compensation on GVBP. When received and confirmed we will disclose it.This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. MonsterStox.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. MonsterStox.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. MonsterStox.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. MonsterStox.com, nor any of its affiliates are not registered investment advisors or a broker dealers.